dc.contributor.author | 世界卫生大会, 57 | |
dc.coverage.spatial | 日内瓦 | en |
dc.date.accessioned | 2012-03-23T07:54:29Z | |
dc.date.available | 2012-03-23T07:54:29Z | |
dc.date.issued | 2004 | |
dc.identifier.govdoc | A57/15 | |
dc.identifier.uri | https://iris.who.int/handle/10665/22902 | |
dc.description | 第五十七届世界卫生大会,临时议程项目12.12 | en |
dc.language.iso | zh | en |
dc.publisher | 世界卫生组织 | en |
dc.relation.uri | https://iris.who.int/handle/10665/22902 | |
dc.subject | Pharmaceutical products | en |
dc.subject | Blood safety | en |
dc.subject.mesh | Drug Industry | en |
dc.subject.mesh | Drug Monitoring | en |
dc.subject.mesh | Pharmaceutical Preparations | en |
dc.subject.mesh | Blood | en |
dc.subject.mesh | Blood Substitutes | en |
dc.subject.mesh | Commerce | en |
dc.subject.mesh | Interinstitutional Relations | en |
dc.title | 药物质量和安全:管制制度:秘书处的报告 | en |
dc.type | Governing body documents | en |
dc.subject.meshqualifier | standards | en |
dc.subject.meshqualifier | legislation and jurisprudence | en |
who.relation.languageVersion | 10665/20909 | en |
who.relation.languageVersion | 10665/20750 | en |
who.relation.languageVersion | 10665/20091 | en |
who.relation.languageVersion | 10665/22413 | en |
who.relation.languageVersion | 10665/21235 | en |